Citation: Jg. Jackson et al., Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines, ONCOGENE, 20(50), 2001, pp. 7318-7325
Citation: Jg. Jackson et al., Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential, CLIN CANC R, 6(3), 2000, pp. 1135-1139
Authors:
Jackson, JG
Kreisberg, JI
Koterba, AP
Yee, D
Brattain, M
Citation: Jg. Jackson et al., Phosphorylation and nuclear exclusion of the forkhead transcription factorFKHR after epidermal growth factor treatment in human breast cancer cells, ONCOGENE, 19(40), 2000, pp. 4574-4581
Citation: Jg. Jackson et D. Yee, IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells, GROWTH H I, 9(5), 1999, pp. 280-289
Authors:
Lee, AV
Jackson, JG
Gooch, JL
Hilsenbeck, SG
Coronado-Heinsohn, E
Osborne, CK
Yee, D
Citation: Av. Lee et al., Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo, MOL ENDOCR, 13(5), 1999, pp. 787-796
Authors:
Durham, SK
Suwanichkul, A
Scheimann, AO
Yee, D
Jackson, JG
Barr, FB
Powell, DR
Citation: Sk. Durham et al., FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter, ENDOCRINOL, 140(7), 1999, pp. 3140-3146